Veterinary Vaccines: Global Markets
Report Highlights
The global veterinary vaccines market reached $9.1 billion in 2022, should reach $9.6 billion by 2023 and $14.2 billion by 2028 with a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2023-2028.
Report Includes
- 145 data tables and 45 additional tables
- A comprehensive overview of the current and future global markets for veterinary vaccines
- Analyses of the global market trends, with historic market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for global veterinary vaccines market in USD millions, and corresponding market share analysis based on the product, type of attenuated and recombinant vaccines, animal type, route of administration, and region
- Highlights of upcoming market opportunities and trends driving and restricting growth of global veterinary vaccines market and its sub-segments, and major regions and countries involved in the market developments
- In-depth information (facts and figures) concerning major market dynamics (DROs), technology advancements, regulatory aspects, and various macroeconomics factors influencing the demand and progress of this market
- Country specific data and market value analysis for the U.S., Canada, Mexico, Germany, France, Italy, Spain, the UK, Japan, China, India, Australia and New Zealand (ANZ), Brazil, Argentina, South Africa, and GCC countries, among others
- Information about ESG-related developments in the animal health industry, key issues, implementation strategies, and analyses of factors affecting ESG applications in the market
- Identification of the companies engaged in research and development (R&D) of vaccination and vaccine production, emerging technologies, and a SWOT analysis of leading competitors and their market penetration
- Company profiles of major players within the industry, including Boehringer Ingelheim, Dechra, Elanco, Merck & Co. Inc., and Zoetis Services LLC
Report Scope
This report aims to provide a comprehensive study of the global market for veterinary vaccines. It describes the different types of veterinary vaccines products, technology, and their current and historical market revenues.
Veterinary vaccines include designs and different technology along with applications. The product of veterinary vaccines are segmented into attenuated vaccine (live vaccine, modified live vaccine, live attenuated vaccine), inactivated vaccine, recombinant vaccine (subunit vaccine, polysaccharide vaccine, conjugate vaccine, chimeric vaccine, viral-vector vaccine), and toxoid vaccine.
This report also covers a detailed study of animal species in the veterinary vaccines market, including livestock, poultry, companion animals, swine, equine, and others (aquaculture, etc.) An in-depth analysis of the global market for veterinary vaccines includes historical data and market projections on sales by technology/system type, product, application, design, and region.
For an in-depth understanding of the market, profiles of market participants, essential marketed products, competitive landscape, key competitors, ESG analysis, and their respective market shares have been provided. This report also discusses the driving and restraining factors of the global veterinary vaccines market.
Frequently Asked Questions (FAQs)
- Incidence and Prevalence of Animal Disease
- Global Warming and Impact on Veterinary Animals
- Increase in Investment for treating and Eradicating Diseases among Animals
- The Emergence of Zoonotic Diseases
- Rise in Awareness Programs on Veterinary Vaccines
- Vaccines and Food Production
- Zoetis Services LLC
- Boehringer Ingelheim International GmbH
- Elanco
- Merck & Co., Inc.
- Virbac
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2022 |
| Forecast period considered | 2023-2028 |
| Base year market size | $9.1 billion |
| Market size forecast | $14.2 billion |
| Growth rate | CAGR of 8.2% for the forecast period of 2023-2028 |
| Units considered | $ Millions |
| Segments covered | Product, Attenuated Vaccines, Recombinant Vaccine, Type of Animal, Administration |
| Regions covered | North America, Europe, Asia-Pacific, Latin America (LATAM), Middle East & Africa (MEA) |
| Countries covered | U.S., Mexico, Canada, France, Germany, U.K., Italy, Spain, Rest of Europe, China, India, Japan, Australia & New Zealand, Rest of APAC, Argentina, Brazil, Rest of LATAM, South Africa, GCC Countries, Rest of MEA |
| Key Market Drivers |
|
| Companies studied |
|